"10.1371_journal.pone.0050307","plos one","2012-11-26T00:00:00Z","Alexandra U Scherrer; Jürg Böni; Sabine Yerly; Thomas Klimkait; Vincent Aubert; Hansjakob Furrer; Alexandra Calmy; Matthias Cavassini; Luigia Elzi; Pietro L Vernazza; Enos Bernasconi; Bruno Ledergerber; Huldrych F Günthard; the Swiss HIV Cohort Study (SHCS)","Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zürich, University of Zürich, Zürich, Switzerland; Institute of Medical Virology, Swiss National Center for Retroviruses, University of Zürich, Zürich, Switzerland; Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland; Department Biomedicine, Haus Peterplatz, University of Basel, Basel, Switzerland; Division of Immunology and Allergy, University Hospital Lausanne, Lausanne, Switzerland; Division of Infectious Diseases, Clinic for Infectious Diseases, University Hospital Berne, University of Berne, Berne, Switzerland; Division of Infectious Diseases, University Hospitals Geneva, Geneva, Switzerland; Infectious Diseases Service, University Hospital Lausanne, Lausanne, Switzerland; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland; Division of Infectious Diseases, Cantonal Hospital St. Gallen, St. Gallen, Switzerland; Regional Hospital Lugano, Lugano, Switzerland","Conceived and designed the experiments: AUS BL HFG. Performed the experiments: JB SY TK VA. Analyzed the data: AUS. Contributed reagents/materials/analysis tools: HF AC MC LE PLV EB. Wrote the paper: AUS HFG.","HFG has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Novartis, Boehringer Ingelheim, Roche, Tibotec and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, GlaxoSmithKline, Gilead, Tibotec and Merck Sharp & Dohme (all money went to institution). SY has participated in advisory boards of BMS and Tibotec, and has received travel grants from GSK and MSD. TK served as advisor for BMS and Pfizer and has received travel grants from Abbott and Pfizer. EB has been adviser and/or consultant for Gilead, Merck Sharp & Dohme, Janssen, ViiV, and Bristol-Myers Squibb. He also received travel grants from Abbott, Gilead, Merck Sharp & Dohme, Janssen, and ViiV. All others reported no conflict of interest.","2012","11","Alexandra U Scherrer","AUS",14,TRUE,3,4,1,2,TRUE,TRUE,TRUE,1,"14",TRUE
